Merck & Co Inc
NYSE: MRK
$99.25
-$0.60 (-0.6%)
Closing Price on January 10, 2025
MRK Articles
Jon OggShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in June and rising interest rates are obviously making short...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Jon OggShort sellers have really made some big changes...
Published:
Jon OggShort sellers could have cleaned up by betting against the high dividend stocks in May and into June. Investors got a whiff of what rising interest rates might mean to their premium dividend...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. This last week had much more volatility than what...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. U.S. equity markets opened higher this morning following...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Jon OggThe bull market appears to still be alive and...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockShort sellers are have previously been all...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013. They include Eli Lilly, W.R. Grace, Intelsat and GlaxoSmithKline.
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockSony Corp. (NYSE: SNE) cuts forecasts for game...
Published:
Last Updated:
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Published:
On the surface it looks like short sellers are all over the place in the latest short interest report. The April 30 settlement date is after many companies had their earnings reports. We saw some...
Published:
Last Updated:
U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP...
Published:
Last Updated:
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.